Elanco is a multinational pharmaceutical company based in the United States. It specializes in the development and manufacturing of products for animal health and welfare. As a subsidiary of Eli Lilly and Company, Elanco operates independently as a global leader in the animal health industry.

Founded in 1954, Elanco began as the animal health division of Eli Lilly and Company. Over the years, it has grown through various acquisitions and mergers to become a prominent player in the sector. The company is headquartered in Greenfield, Indiana, but has a global presence with operations in more than 90 countries.

Elanco offers a wide range of products and services targeted at improving animal health and productivity. Its portfolio includes pharmaceuticals for both livestock and companion animals, vaccines, feed additives, and other solutions to promote animal well-being. The company focuses on innovative research and development to address the evolving needs of farmers, veterinarians, and pet owners.

On a global scale, Elanco has established several noteworthy subsidiaries, joint ventures, and partnerships. These include Elanco Canada, Elanco Mexico, Elanco Animal Health International, and Elanco Korea, among others. It collaborates with industry leaders, regulatory bodies, and research institutes to enhance its product offerings and expand its presence worldwide.

Elanco holds a significant market position in the animal health industry. It consistently ranks among the top global animal health companies in terms of sales. With a strong emphasis on innovation, it competes with other major players in the market, such as Zoetis and Merck Animal Health.

In recent years, Elanco has embarked on a strategy aimed at growth and diversification. It has made strategic acquisitions to expand its product portfolio and global footprint. Notably, in 2020, Elanco completed the acquisition of Bayer Animal Health, positioning itself as one of the largest animal health companies worldwide.

As of the latest available information, Elanco continues to evolve and expand its presence in the animal health industry. With its focus on research and development, strategic acquisitions, and commitment to animal health and welfare, Elanco remains a key player in the global market